IL17A and psoriasis: These may be the reason for the fact that germ-free mice and antibiotic-treated mice were more resistant to psoriasis-like inflammation induced by imiquimod, including a lower degree of Th17 activation, less IL-17 production and a lower number of IFN-γ + T cells (51).